Distinct phenotype and therapeutic potential of gingival fibroblasts

Cytotherapy

Volumn 16, Issue 9, 2014, Pages 1171-1186

  Häkkinen, Lari ^a   Larjava, Hannu ^a   Fournier, Benjamin P J ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Fibroblast; Gingiva; Phenotype; Therapy; Tissue regeneration

Indexed keywords

BIOPSY; CELL ISOLATION; CELL PRODUCT; CELL SUBPOPULATION; CELL THERAPY; CELLS; FIBROBLAST; GENE EXPRESSION; GINGIVA; GINGIVAL FIBROBLAST; HUMAN; IMMUNOMODULATION; MOUTH MUCOSA; NEURAL CREST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN FIBROBLAST; TISSUE REGENERATION; WOUND HEALING; BIOLOGICAL THERAPY; CELL DIFFERENTIATION; CYTOLOGY; PROCEDURES; STEM CELL NICHE; TRANSPLANTATION;

CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; FIBROBLASTS; GINGIVA; GUIDED TISSUE REGENERATION; HUMANS; MOUTH MUCOSA; PHENOTYPE; STEM CELL NICHE; WOUND HEALING;

EID: 84905584820     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.04.004     Document Type: Review

References (164)

1. Haniffa M.A., Collin M.P., Buckley C.D., Dazzi F. Mesenchymal stem cells: the fibroblasts' new clothes?. Haematologica 2009, 94:258-263.
2. Räsänen K., Vaheri A. Activation of fibroblasts in cancer stroma. Exp Cell Res 2010, 316:2713-2722.
3. Häkkinen L., Larjava H., Koivisto L. Granulation tissue formation and remodeling. Endodontic Topics 2012, 24:94-129.
4. Sorrell J.M., Caplan A.I. Fibroblast heterogeneity: more than skin deep. J Cell Sci 2004, 117:667-675.
5. Fournier B.P.J., Larjava H., Häkkinen L. Gingiva as a source of stem cells with therapeutic potential. Stem Cells Dev 2013, 22:3157-3177.
6. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
7. Bieback K., Wuchter P., Besser D., Franke W., Becker M., Ott M., et al. Mesenchymal stromal cells (MSCs): science and f(r)iction. J Mol Med 2012, 90:773-782.
8. Mao J.J., Prockop D.J. Stem cells in the face: tooth regeneration and beyond. Cell Stem Cell 2012, 11:291-301.
9. Bayreuther K., Rodemann H.P., Francz P.I., Maier K. Differentiation of fibroblast stem cells. J Cell Sci Suppl 1988, 10:115-130.
10. Häkkinen L., Larjava H. Characterization of fibroblast clones from periodontal granulation tissue in vitro. J Dent Res 1992, 71:1901-1907.
11. Irwin C.R., Picardo M., Ellis I., Sloan P., Grey A., McGurk M., et al. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sci 1994, 107:1333-1346.
12. Chang H.Y., Chi J.T., Dudoit S., Bondre C., van de Rijn M., Botstein D., et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002, 99:12877-12882.
13. Schor S.L., Ellis I., Irwin C.R., Banyard J., Seneviratne K., Dolman C., et al. Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease. Oral Dis 1996, 2:155-166.
14. Herzog E.L., Bucala R. Fibrocytes in health and disease. Exp Hematol 2010, 38:548-556.
15. Hassell T.M., Stanek E.J. Evidence that healthy human gingiva contains functionally heterogeneous fibroblast subpopulations. Arch Oral Biol 1983, 28:617-625.
16. Schor S.L., Schor A.M., Grey A.M., Rushton G. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J Cell Sci 1988, 90:391-399.
17. Grey A.M., Schor A.M., Rushton G., Ellis I., Schor S.L. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci U S A 1989, 86:2438-2442.
18. Ko S.D., Page R.C., Narayanan A.S. Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci U S A 1977, 74:3429-3432.
19. Bordin S., Page R.C., Narayanan A.S. Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. Science 1984, 223:171-173.
20. Hassell T.M., Romberg E., Sobhani S., Lesko L., Douglas R. Lymphocyte-mediated effects of cyclosporine on human fibroblasts. Transplant Proc 1988, 20:993-1002.
21. Fries K.M., Blieden T., Looney R.J., Sempowski G.D., Silvera M.R., Willis R.A., et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994, 72:283-292.
22. Sempowski G.D., Borrello M.A., Blieden T.M., Barth R.K., Phipps R.P. Fibroblast heterogeneity in the healing wound. Wound Repair Regen 1995, 3:120-131.
23. Lekic P.C., Pender N., McCulloch C.A. Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues?. Crit Rev Oral Biol Med 1997, 8:253-268.
24. Gagari E., Rand M.K., Tayari L., Vastardis H., Sharma P., Hauschka P.V., et al. Expression of stem cell factor and its receptor, c-kit, in human oral mesenchymal cells. Eur J Oral Sci 2006, 114:409-415.
25. Bordin S., Costa L.G., Tan X. Fibroblast heterogeneity of signal transduction mechanisms to complement-C1q: analyses of calcium mobilization, inositol phosphate accumulation, and protein kinases-C redistribution. J Periodontol 1998, 69:642-649.
26. Trackman P.C., Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004, 15:165-175.
27. Hassell T.M., Gilbert G.H. Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am J Pathol 1983, 112:218-223.
28. Stabellini G., Calastrini C., Mariani G., Gioia M., Caramelli E., Gagliano N., et al. Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments. J Oral Pathol Med 2004, 33:346-353.
29. Shin D., Minn K.W. The effect of myofibroblast on contracture of hypertrophic scar. Plast Reconstr Surg 2004, 113:633-640.
30. Bucala R., Spiegel L.A., Chesney J., Hogan M., Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71-81.
31. Kaltschmidt B., Kaltschmidt C., Widera D. Adult craniofacial stem cells: sources and relation to the neural crest. Stem Cell Rev 2011, 8:658-671.
32. Karring T., Ostergaard E., Loe H. Conservation of tissue specificity after heterotopic transplantation of gingiva and alveolar mucosa. J Periodont Res 1971, 6:282-293.
33. Karring T., Lang N.P., Loe H. The role of gingival connective tissue in determining epithelial differentiation. J Periodont Res 1975, 10:1-11.
34. Schroeder H. Oral Structural Biology 1991, Thieme Medical Publisher, New York, New York, USA.
35. Winning T.A., Townsend G.C. Oral mucosal embryology and histology. Clin Dermatol 2000, 18:499-511.
36. Mak K., Manji A., Gallant-Behm C., Wiebe C., Hart D.A., Larjava H., et al. Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model. J Dermatol Sci 2009, 56:168-180.
37. Wong J.W., Gallant-Behm C., Wiebe C., Mak K., Hart D.A., Larjava H., et al. Wound healing in oral mucosa results in reduced scar formation as compared with skin: evidence from the red Duroc pig model and humans. Wound Repair Regen 2009, 17:717-729.
38. Glim J.E., van Egmond M., Niessen F.B., Everts V., Beelen R.H. Detrimental dermal wound healing: what can we learn from the oral mucosa?. Wound Repair Regen 2013, 21:648-660.
39. Sciubba J.J., Waterhouse J.P., Meyer J. A fine structural comparison of the healing of incisional wounds of mucosa and skin. J Oral Pathol 1978, 7:214-227.
40. Szpaderska A.M., Zuckerman J.D., DiPietro L.A. Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 2003, 82:621-626.
41. Zelles T., Purushotham K.R., Macauley S.P., Oxford G.E., Humphreys-Beher M.G. Saliva and growth factors: the fountain of youth resides in us all. J Dent Res 1995, 74:1826-1832.
42. Häkkinen L., Uitto V.J., Larjava H. Cell biology of gingival wound healing. Periodontol 2000 2000, 24:127-152.
43. Angelov N., Moutsopoulos N., Jeong M.J., Nares S., Ashcroft G., Wahl S.M. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor. Thromb Haemost 2004, 92:288-297.
44. Oudhoff M.J., Bolscher J.G., Nazmi K., Kalay H., van 't Hof W., Amerongen A.V., et al. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J 2008, 22:3805-3812.
45. Imamura Y., Wang P.L. Salivary histatin 3 inhibits heat shock cognate protein 70-mediated inflammatory cytokine production through toll-like receptors in human gingival fibroblasts. J Inflamm 2014, 11:4.
46. Chavrier C. The elastic system fibres in healthy human gingiva. Arch Oral Biol 1990, 35(Suppl):223S-225S.
47. Hsieh P.C., Jin Y.T., Chang C.W., Huang C.C., Liao S.C., Yuan K. Elastin in oral connective tissue modulates the keratinization of overlying epithelium. J Clin Periodontol 2010, 37:705-711.
48. Goktas S., Dmytryk J.J., McFetridge P.S. Biomechanical behavior of oral soft tissues. J Periodontol 2011, 82:1178-1186.
49. Eslami A., Gallant-Behm C.L., Hart D.A., Wiebe C., Honardoust D., Gardner H., et al. Expression of integrin alphavbeta6 and TGF-beta in scarless vs scar-forming wound healing. J Histochem Cytochem 2009, 57:543-557.
50. Namazi M.R., Fallahzadeh M.K., Schwartz R.A. Strategies for prevention of scars: what can we learn from fetal skin?. Int J Dermatol 2011, 50:85-93.
51. Mah W., Jiang G., Olver D., Cheung G., Kim B., Larjava H., et al. Human gingival fibroblasts display a non-fibrotic phenotype distinct from skin fibroblasts in three-dimensional cultures. PloS One 2014, 9:e90715.
52. Cho M.I., Garant P.R. Development and general structure of the periodontium. Periodontology 2000, 24:9-27.
53. Schroeder H.E., Lindhe J., Hugoson A., Munzel-Pedrazzoli S. Structural constituents of clinically normal and slightly inflamed dog gingiva: a morphometric study. Helv Odontol Acta 1973, 17:70-83.
54. Beertsen W., McCulloch C.A., Sodek J. The periodontal ligament: a unique, multifunctional connective tissue. Periodontol 2000 1997, 13:20-40.
55. Somerman M.J., Archer S.Y., Imm G.R., Foster R.A. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 1988, 67:66-70.
56. Groeneveld M.C., Everts V., Beertsen W. Alkaline phosphatase activity in the periodontal ligament and gingiva of the rat molar: its relation to cementum formation. J Dent Res 1995, 74:1374-1381.
57. Giannopoulou C., Cimasoni G. Functional characteristics of gingival and periodontal ligament fibroblasts. J Dent Res 1996, 75:895-902.
58. Locke M., Hyland P.L., Irwin C.R., Mackenzie I.C. Modulation of gingival epithelial phenotypes by interactions with regionally defined populations of fibroblasts. J Periodont Res 2008, 43:279-289.
59. Lackler K.P., Cochran D.L., Hoang A.M., Takacs V., Oates T.W. Development of an in vitro wound healing model for periodontal cells. J Periodontol 2000, 71:226-237.
60. Morandini A.C., Sipert C.R., Gasparoto T.H., Greghi S.L., Passanezi E., Rezende M.L., et al. Differential production of macrophage inflammatory protein-1alpha, stromal-derived factor-1, and IL-6 by human cultured periodontal ligament and gingival fibroblasts challenged with lipopolysaccharide from P. gingivalis. J Periodontol 2010, 81:310-317.
61. Sempowski G.D., Chess P.R., Moretti A.J., Padilla J., Phipps R.P., Blieden T.M. CD40 mediated activation of gingival and periodontal ligament fibroblasts. J Periodontol 1997, 68:284-292.
62. Fujita T., Iwata T., Shiba H., Igarashi A., Hirata R., Takeda K., et al. Identification of marker genes distinguishing human periodontal ligament cells from human mesenchymal stem cells and human gingival fibroblasts. J Periodont Res 2007, 42:283-286.
63. Pender N., McCulloch C.A. Quantitation of actin polymerization in two human fibroblast sub-types responding to mechanical stretching. J Cell Sci 1991, 100:187-193.
64. Worapamorn W., Li H., Haas H.R., Pujic Z., Girjes A.A., Bartold P.M. Cell surface proteoglycan expression by human periodontal cells. Connect Tissue Res 2000, 41:57-68.
65. Tsuruga E., Irie K., Sakakura Y., Yajima T. Expression of fibrillins and tropoelastin by human gingival and periodontal ligament fibroblasts in vitro. J Periodont Res 2002, 37:23-28.
66. Bayat A., McGrouther D.A., Ferguson M.W.J. Skin scarring. Br Med J 2003, 326:88-92.
67. Metcalfe A.D., Ferguson M.W. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 2007, 4:413-437.
68. Occleston N.L., O'Kane S., Goldspink N., Ferguson M.W. New therapeutics for the prevention and reduction of scarring. Drug Discov Today 2008, 13:973-981.
69. Bombaro K.M., Engrav L.H., Carrougher G.J., Wiechman S.A., Faucher L., Costa B.A., et al. What is the prevalence of hypertrophic scarring following burns?. Burns 2003, 29:299-302.
70. Greaves N.S., Iqbal S.A., Baguneid M., Bayat A. The role of skin substitutes in the management of chronic cutaneous wounds. Wound Repair Regen 2013, 21:194-210.
71. Kagan R.J., Peck M.D., Ahrenholz D.H., Hickerson W.L., Holmes J., Korentager R., et al. Surgical management of the burn wound and use of skin substitutes: an expert panel white paper. J Burn Care Res 2013, 34:e60-e79.
72. Shahrokhi S., Arno A., Jeschke M.G. The use of dermal substitutes in burn surgery: acute phase. Wound Repair Regen 2014, 22:14-22.
73. Wong T., McGrath J.A., Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 2007, 156:1149-1155.
74. Greenhalgh D.G. The use of dermal substitutes in burn surgery: acute phase. Wound Repair Regen 2014, 22:1-2.
75. Fernandes K.J., Toma J.G., Miller F.D. Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential. Philos Trans R Soc Lond B Biol Sci 2008, 363:185-198.
76. Shakhova O, Sommer L. Neural Crest-Derived Stem Cells. StemBook, Cambridge, Massachusetts, USA: Harvard Stem Cell Institute; 2010:2008.
77. Chai Y., Jiang X., Ito Y., Bringas P., Han J., Rowitch D.H., et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000, 127:1671-1679.
78. Xu X., Chen C., Akiyama K., Chai Y., Le A.D., Wang Z., Shi S. gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells. J Dent Res 2013, 92:825-832.
79. Parsonage G., Filer A.D., Haworth O., Nash G.B., Rainger G.E., Salmon M., et al. A stromal address code defined by fibroblasts. Trends Immunol 2005, 26:150-156.
80. Rinn J.L., Wang J.K., Liu H., Montgomery K., van de Rijn M., Chang H.Y. A systems biology approach to anatomic diversity of skin. J Invest Dermatol 2008, 128:776-782.
81. Rinn J.L., Bondre C., Gladstone H.B., Brown P.O., Chang H.Y. Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2006, 2:e119.
82. Guo F., Carter D.E., Mukhopadhyay A., Leask A. Gingival fibroblasts display reduced adhesion and spreading on extracellular matrix: a possible basis for scarless tissue repair?. PLoS One 2011, 6:e27097.
83. Ebisawa K., Kato R., Okada M., Sugimura T., Latif M.A., Hori Y., et al. Gingival and dermal fibroblasts: their similarities and differences revealed from gene expression. J Biosci Bioeng 2011, 111:255-258.
84. Brizzi M.F., Tarone G., Defilippi P. Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol 2012, 24:645-651.
85. Pedlar J. Biochemistry of glycosaminoglycans in the skin and oral mucosa of the rat. Arch Oral Biol 1984, 29:591-597.
86. Bronson R.E., Argenta J.G., Siebert E.P., Bertolami C.N. Distinctive fibroblastic subpopulations in skin and oral mucosa demonstrated by differences in glycosaminoglycan content. In Vitro Cell Dev Biol 1988, 24:1121-1126.
87. Larjava H., Heino J., Krusius T., Vuorio E., Tammi M. The small dermatan sulphate proteoglycans synthesized by fibroblasts derived from skin, synovium and gingiva show tissue-related heterogeneity. Biochem J 1988, 256:35-40.
88. Palaiologou A.A., Yukna R.A., Moses R., Lallier T.E. Gingival, dermal, and periodontal ligament fibroblasts express different extracellular matrix receptors. J Periodontol 2001, 72:798-807.
89. Irwin C.R., Myrillas T., Smyth M., Doogan J., Rice C., Schor S.L. Regulation of fibroblast-induced collagen gel contraction by interleukin-1beta. J Oral Pathol Med 1998, 27:255-259.
90. Lorimier S., Hornebeck W., Godeau G., Pellat B., Gillery P., Maquart F.X., et al. Morphometric studies of collagen and fibrin lattices contracted by human gingival fibroblasts; comparison with dermal fibroblasts. J Dent Res 1998, 77:1717-1729.
91. Chaussain Miller C., Septier D., Bonnefoix M., Lecolle S., Lebreton-Decoster C., Coulomb B., et al. Human dermal and gingival fibroblasts in a three-dimensional culture: a comparative study on matrix remodeling. Clin Oral Invest 2002, 6:39-50.
92. Grinnell F., Petroll W.M. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol 2010, 26:335-361.
93. Schor S.L., Ellis I.R., Jones S.J., Baillie R., Seneviratne K., Clausen J., et al. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Res 2003, 63:8827-8836.
94. Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., Matsuo T. Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts. Clin Exp Immunol 2006, 144:494-502.
95. Okada Y., Meguro M., Ohyama H., Yoshizawa S., Takeuchi-Hatanaka K., Kato N., et al. Human leukocyte histocompatibility antigen class II-induced cytokines from human gingival fibroblasts promote proliferation of human umbilical vein endothelial cells: potential association with enhanced angiogenesis in chronic periodontal inflammation. J Periodont Res 2009, 44:103-109.
96. McKeown S.T., Hyland P.L., Locke M., Mackenzie I.C., Irwin C.R. Keratinocyte growth factor and scatter factor expression by regionally defined oral fibroblasts. Eur J Oral Sci 2003, 111:42-50.
97. Chinnathambi S., Bickenbach J.R. Human skin and gingival keratinocytes show differential regulation of matrix metalloproteinases when combined with fibroblasts in 3-dimensional cultures. J Periodontol 2005, 76:1072-1083.
98. Koivisto L., Larjava H., Häkkinen L. Reepithelialization of wounds. Endodontic Topics 2012, 24:59-93.
99. Lerner U.H., Modeer T. Bradykinin B1 and B2 receptor agonists synergistically potentiate interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts. Inflammation 1991, 15:427-436.
100. Niisato N., Ogata Y., Furuyama S., Sugiya H. Histamine H1 receptor-induced Ca2+ mobilization and prostaglandin E2 release in human gingival fibroblasts: possible role of receptor-operated Ca2+ influx. Biochem Pharmacol 1996, 52:1015-1023.
101. Murakami S., Okada H. Lymphocyte-fibroblast interactions. Crit Rev Oral Biol Med 1997, 8:40-50.
102. Takashiba S., Naruishi K., Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol 2003, 74:103-110.
103. Costa-Rodrigues J., Fernandes M.H. Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts. Cell Prolif 2011, 44:264-273.
104. Dufour A., Overall C.M. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 2013, 34:233-242.
105. Tardif F., Ross G., Rouabhia M. Gingival and dermal fibroblasts produce interleukin-1 beta converting enzyme and interleukin-1 beta but not interleukin-18 even after stimulation with lipopolysaccharide. J Cell Physiol 2004, 198:125-132.
106. Weinberg E., Topaz M., Dard M., Lyngstadaas P., Nemcovsky C., Weinreb M. Differential effects of prostaglandin E(2) and enamel matrix derivative on the proliferation of human gingival and dermal fibroblasts and gingival keratinocytes. J Periodont Res 2010, 45:731-740.
107. Black S.A., Palamakumbura A.H., Stan M., Trackman P.C. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem 2007, 282:15416-15429.
108. Guo F., Carter D.E., Leask A. Mechanical tension increases CCN2/CTGF expression and proliferation in gingival fibroblasts via a TGFb-dependent mechanism. PLoS One 2011, 6:e19756.
109. Guo F., Carter D.E., Leask A. miR-218 regulates focal adhesion kinase-dependent TGFβ signaling in fibroblasts. Mol Biol Cell 2014, 7:1151-1158.
110. Wada N., Menicanin D., Shi S., Bartold P.M., Gronthos S. Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol 2009, 219:667-676.
111. Cappellesso-Fleury S., Puissant-Lubrano B., Apoil P.A., Titeux M., Winterton P., Casteilla L., et al. Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 2010, 30:607-619.
112. Séguier S., Tartour E., Guérin C., Couty L., Lemitre M., Lallement L., et al. Inhibition of the differentiation of monocyte-derived dendritic cells by human gingival fibroblasts. PLoS One 2013, 8:e70937.
113. Shimabukuro Y., Murakami S., Okada H. Interferon-gamma-dependent immunosuppressive effects of human gingival fibroblasts. Immunology 1992, 76:344-347.
114. Takahashi K., Takigawa M., Takashiba S., Nagai A., Miyamoto M., Kurihara H., et al. Role of cytokine in the induction of adhesion molecules on cultured human gingival fibroblasts. J Periodontol 1994, 65:230-235.
115. Shimabukuro Y., Murakami S., Okada H. Antigen-presenting-cell function of interferon gamma-treated human gingival fibroblasts. J Periodont Res 1996, 31:217-228.
116. Mahanonda R., Sa-Ard-Iam N., Montreekachon P., Pimkhaokham A., Yongvanichit K., Fukuda M.M., et al. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol 2007, 178:1151-1157.
117. Gogly B., Naveau A., Fournier B., Reinald N., Durand E., Brasselet C., et al. Preservation of rabbit aorta elastin from degradation by gingival fibroblasts in an ex vivo model. Arterioscler Thromb Vasc Biol 2007, 27:1984-1990.
118. Durand E., Fournier B., Couty L., Lemitre M., Achouh P., Julia P., et al. Endoluminal gingival fibroblast transfer reduces the size of rabbit carotid aneurisms via elastin repair. Arterioscler Thromb Vasc Biol 2012, 32:1892-1901.
119. Metcalfe A.D., Ferguson M.W. Bioengineering skin using mechanisms of regeneration and repair. Biomaterials 2007, 28:5100-5113.
120. Wong T., Gammon L., Liu L., Mellerio J.E., Dopping-Hepenstal P.J., Pacy J., et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008, 128:2179-2189.
121. Felder J.M., Goyal S.S., Attinger C.E. A systematic review of skin substitutes for foot ulcers. Plast Reconstr Surg 2012, 130:145-164.
122. Tziotzios C., Profyris C., Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics, part II: strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol 2012, 66:13-24.
123. Oliver R.C., Loe H., Karring T. Microscopic evaluation of the healing and revascularization of free gingival grafts. J Periodont Res 1968, 3:84-95.
124. Guiha R., el Khodeiry S., Mota L., Caffesse R. Histological evaluation of healing and revascularization of the subepithelial connective tissue graft. J Periodontol 2001, 72:470-478.
125. Siegel R.J. Palatal grafts for eyelid reconstruction. Plast Reconstr Surg 1985, 76:411-414.
126. Swamy B.N., Benger R., Taylor S. Cicatricial entropion repair with hard palate mucous membrane graft: surgical technique and outcomes. Clin Exp Ophthalmol 2008, 36:348-352.
127. Bartley G.B., Kay P.P. Posterior lamellar eyelid reconstruction with a hard palate mucosal graft. Am J Ophthalmol 1989, 107:609-612.
128. Yoshimura Y., Nakajima T., Yoneda K. Use of the palatal mucosal graft for reconstruction of the eye socket. J Craniomaxillofac Surg 1995, 23:27-30.
129. Miyamoto J., Nakajima T., Nagasao T., Konno E., Okabe K., Tanaka T., et al. Full-thickness reconstruction of the eyelid with rotation flap based on orbicularis oculi muscle and palatal mucosal graft: long-term results in 12 cases. J Plast Reconstr Aesthet Surg 2009, 62:1389-1394.
130. Ito O., Suzuki S., Park S., Muneuchi G., Kawazoe T., Saso Y., et al. Usefulness of palatal mucoperiosteal grafts for artificial eye socket contracture. Ann Plast Surg 2003, 51:278-282.
131. Weinberg D.A., Tham V., Hardin N., Antley C., Cohen A.J., Hunt K., et al. Eyelid mucous membrane grafts: a histologic study of hard palate, nasal turbinate, and buccal mucosal grafts. Ophthal Plast Reconstr Surg 2007, 23:211-216.
132. Nakajima T., Yoshimura Y. Secondary correction of bilateral cleft lip nose deformity. J Craniomaxillofac Surg 1990, 18:63-67.
133. Yoshimura Y., Nakajima T. Tracheoplasty with palatal mucoperiosteal graft. Plast Reconstr Surg 1990, 86:558-562.
134. Humby G.A. one-stage operation for hypospadias. Br J Surg 1941, 29:84-92.
135. Burger R.A., Muller S.C., el-Damanhoury H., Tschakaloff A., Riedmiller H., Hohenfellner R. The buccal mucosal graft for urethral reconstruction: a preliminary report. J Urol 1992, 147:662-664.
136. Fichtner J., Filipas D., Fisch M., Hohenfellner R., Thuroff J.W. Long-term outcome of ventral buccal mucosa onlay graft urethroplasty for urethral stricture repair. Urology 2004, 64:648-650.
137. Bhargava S., Chapple C.R. Buccal mucosal urethroplasty: is it the new gold standard?. BJU Int 2004, 93:1191-1193.
138. Filipas D., Fisch M., Fichtner J., Fitzpatrick J., Berg K., Storkel S., et al. The histology and immunohistochemistry of free buccal mucosa and full-skin grafts after exposure to urine. BJU Int 1999, 84:108-111.
139. Fichtner J., Filipas D., Fisch M., Hohenfellner R., Thuroff J.W. Long-term followup of buccal mucosa onlay graft for hypospadias repair: analysis of complications. J Urol 2004, 172:1970-1972.
140. Markiewicz M.R., DeSantis J.L., Margarone J.E., Pogrel M.A., Chuang S.K. Morbidity associated with oral mucosa harvest for urological reconstruction: an overview. J Oral Maxillofac Surg 2008, 66:739-744.
141. Nagy N., Almaani N., Tanaka A., Lai-Cheong J.E., Techanukul T., Mellerio J.E., et al. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol 2011, 131:1771-1774.
142. Uitto J. Cell-based therapy for RDEB: how does it work?. J Invest Dermatol 2011, 131:1597-1599.
143. Weiss R.A., Weiss M.A., Beasley K.L., Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg 2007, 33:263-268.
144. Yamada N., Uchinuma E., Matsumoto Y., Kuroyanagi Y. Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute. J Artif Organs 2008, 11:221-224.
145. Griffiths M., Ojeh N., Livingstone R., Price R., Navsaria H. Survival of Apligraf in acute human wounds. Tissue Eng 2004, 10:1180-1195.
146. Lamme E.N., van Leeuwen R.T., Mekkes J.R., Middelkoop E. Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen 2002, 10:152-160.
147. Kellar R.S., Williams S.K., Naughton G.K., Figliozzi G.M., Siani-Rose M. Three-dimensional fibroblast cultures stimulate improved ventricular performance in chronically ischemic canine hearts. Tissue Eng Part A 2011, 17:2177-2186.
148. Clarke A.W., Alyas F., Morris T., Robertson C.J., Bell J., Connell D.A. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sports Med 2011, 39:614-623.
149. Bouffi C., Bony C., Jorgensen C., Noel D. Skin fibroblasts are potent suppressors of inflammation in experimental arthritis. Ann Rheum Dis 2011, 70:1671-1676.
150. McGuire M.K., Nunn M.E. Evaluation of the safety and efficacy of periodontal applications of a living tissue-engineered human fibroblast-derived dermal substitute, I: comparison to the gingival autograft: a randomized controlled pilot study. J Periodontol 2005, 76:867-880.
151. McGuire M.K., Scheyer E.T., Nunn M.E., Lavin P.T. A pilot study to evaluate a tissue-engineered bilayered cell therapy as an alternative to tissue from the palate. J Periodontol 2008, 79:1847-1856.
152. Nevins M., Nevins M.L., Amelo M., Camelo J.M., Schupbach P., Kim D.M. The clinical efficacy of DynaMatrix extracellular membrane in augmenting keratinized tissue. Int J Periodon Restorative Dent 2010, 30:151-161.
153. Nevins M.L. Tissue-engineered bilayered cell therapy for the treatment of oral mucosal defects: a case series. Int J Periodon Restorative Dent 2010, 30:31-39.
154. McGuire M.K., Scheyer E.T., Nevins M., Neiva R., Cochran D.L., Mellonig J.T., et al. Living Cellular Construct for Increasing the Width of Keratinized Gingiva: results from a randomized, within-patient, controlled trial. J Periodontol 2011, 82:1414-1423.
155. Scheyer E.T., Nevins M.L., Neiva R., Cochran D.L., Giannobile W.V., Woo S.B., et al. Generation of site-appropriate tissue by a living cellular sheet in the treatment of mucogingival defects. J Periodontol 2013, 85:e57-e64.
156. Moharamzadeh K., Colley H., Murdoch C., Hearnden V., Chai W.L., Brook I.M., et al. Tissue-engineered oral mucosa. J Dent Re 2012, 91:642-650.
157. Prato G.P., Rotundo R., Magnani C., Soranzo C., Muzzi L., Cairo F. An autologous cell hyaluronic acid graft technique for gingival augmentation: a case series. J Periodontol 2003, 74:262-267.
158. McGuire M.K., Scheyer E.T. A randomized, double-blind, placebo-controlled study to determine the safety and efficacy of cultured and expanded autologous fibroblast injections for the treatment of interdental papillary insufficiency associated with the papilla priming procedure. J Periodontol 2007, 78:4-17.
159. Jhaveri H.M., Chavan M.S., Tomar G.B., Deshmukh V.L., Wani M.R., Miller P.D. Acellular dermal matrix seeded with autologous gingival fibroblasts for the treatment of gingival recession: a proof-of-concept study. J Periodontol 2010, 81:616-625.
160. Dominiak M., Saczko J., Gerber H., Rybak Z., Gredes T. The clinical efficacy of primary culture of human fibroblasts in gingival augmentation procedures: a preliminary report. Ann Anat 2012, 194:502-507.
161. Chhetri D.K., Berke G.S. Injection of cultured autologous fibroblasts for human vocal fold scars. Laryngoscope 2011, 121:785-792.
162. Bhargava S., Patterson J.M., Inman R.D., MacNeil S., Chapple C.R. Tissue-engineered buccal mucosa urethroplasty-clinical outcomes. Eur Urol 2008, 53:1263-1269.
163. Kobayashi K., Suzuki T., Nomoto Y., Tada Y., Miyake M., Hazama A., et al. Potential of heterotopic fibroblasts as autologous transplanted cells for tracheal epithelial regeneration. Tissue Eng 2007, 13:2175-2184.
164. Kobayashi K., Suzuki T., Nomoto Y., Tada Y., Miyake M., Hazama A., et al. A tissue-engineered trachea derived from a framed collagen scaffold, gingival fibroblasts and adipose-derived stem cells. Biomaterials 2010, 31:4855-4863.